Cormac D. Murphy

3.6k total citations
107 papers, 2.7k citations indexed

About

Cormac D. Murphy is a scholar working on Molecular Biology, Pharmaceutical Science and Pharmacology. According to data from OpenAlex, Cormac D. Murphy has authored 107 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 21 papers in Pharmaceutical Science and 19 papers in Pharmacology. Recurrent topics in Cormac D. Murphy's work include Microbial Natural Products and Biosynthesis (19 papers), Fluorine in Organic Chemistry (18 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Cormac D. Murphy is often cited by papers focused on Microbial Natural Products and Biosynthesis (19 papers), Fluorine in Organic Chemistry (18 papers) and Pharmacogenetics and Drug Metabolism (12 papers). Cormac D. Murphy collaborates with scholars based in Ireland, United Kingdom and Netherlands. Cormac D. Murphy's co-authors include Steven L. Cobb, David O’Hagan, Christoph Schaffrath, Mohd Faheem Khan, John T. G. Hamilton, Benjamin R. Clark, Eoin Casey, Graham Sandford, Diana Giménez and Steven J. Moss and has published in prestigious journals such as Nature, Angewandte Chemie International Edition and Environmental Science & Technology.

In The Last Decade

Cormac D. Murphy

106 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cormac D. Murphy Ireland 30 1.1k 558 507 366 330 107 2.7k
Helmut Görisch Germany 27 1.4k 1.3× 227 0.4× 146 0.3× 1.1k 3.0× 106 0.3× 78 2.7k
Susanne Fetzner Germany 33 2.3k 2.1× 109 0.2× 321 0.6× 1.2k 3.3× 234 0.7× 114 4.0k
Kazuhiro Chiba Japan 38 1.3k 1.2× 119 0.2× 2.5k 5.0× 478 1.3× 313 0.9× 199 4.8k
Michael Linscheid Germany 38 1.7k 1.6× 237 0.4× 265 0.5× 78 0.2× 135 0.4× 179 4.5k
Gerrit J. Poelarends Netherlands 41 2.5k 2.4× 89 0.2× 1.3k 2.6× 562 1.5× 251 0.8× 159 4.5k
Douglas W. Ribbons United States 31 1.7k 1.5× 132 0.2× 204 0.4× 797 2.2× 110 0.3× 96 2.9k
Ronald D. Snyder United States 38 2.1k 1.9× 128 0.2× 403 0.8× 127 0.3× 188 0.6× 109 3.7k
David L. Zechel Canada 33 2.2k 2.0× 123 0.2× 1.9k 3.7× 342 0.9× 413 1.3× 67 4.0k
Nobuyoshi Esaki Japan 51 4.9k 4.5× 183 0.3× 410 0.8× 798 2.2× 165 0.5× 284 8.1k
Tatsuo Kurihara Japan 41 2.9k 2.7× 98 0.2× 133 0.3× 695 1.9× 87 0.3× 154 4.5k

Countries citing papers authored by Cormac D. Murphy

Since Specialization
Citations

This map shows the geographic impact of Cormac D. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cormac D. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cormac D. Murphy more than expected).

Fields of papers citing papers by Cormac D. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cormac D. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cormac D. Murphy. The network helps show where Cormac D. Murphy may publish in the future.

Co-authorship network of co-authors of Cormac D. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Cormac D. Murphy. A scholar is included among the top collaborators of Cormac D. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cormac D. Murphy. Cormac D. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muldoon, Jimmy, et al.. (2025). Novel Synthesis of the Antifungal Cyclic Lipopeptide Iturin A and Its Fluorinated Analog for Structure‐Activity Relationship Studies. Chemistry - A European Journal. 31(47). e01341–e01341.
2.
Khan, Mohd Faheem, et al.. (2024). Biotransformation of fluorinated drugs and xenobiotics by the model fungus Cunninghamella elegans. Methods in enzymology on CD-ROM/Methods in enzymology. 696. 251–285. 12 indexed citations
3.
Muldoon, Jimmy, et al.. (2024). Total synthesis of antifungal lipopeptide iturin A analogues and evaluation of their bioactivity against F. graminearum. Journal of Peptide Science. 30(6). e3569–e3569. 3 indexed citations
4.
Khan, Mohd Faheem & Cormac D. Murphy. (2022). Cytochrome P450 5208A3 is a promiscuous xenobiotic biotransforming enzyme in Cunninghamella elegans. Enzyme and Microbial Technology. 161. 110102–110102. 21 indexed citations
5.
Khan, Mohd Faheem & Cormac D. Murphy. (2020). 3-Hydroxytyrosol regulates biofilm growth in Cunninghamella elegans. Fungal Biology. 125(3). 211–217. 15 indexed citations
6.
Clark, Benjamin R., et al.. (2018). Antitumor Activity of the Cyclo (L-Phenyl, L-Prolyl) Diketopiperazines Produced By a Newly Isolated Streptomyces Sp. A4.4. 1(5). 1 indexed citations
7.
Sheehan, John P., Cormac D. Murphy, & Patrick Caffrey. (2017). New insights into polyene macrolide biosynthesis in Couchioplanes caeruleus. Molecular BioSystems. 13(5). 866–873. 11 indexed citations
8.
Almahboub, Sarah A., Tanja Narančić, Marc Devocelle, et al.. (2017). Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity. Applied Microbiology and Biotechnology. 102(2). 789–799. 15 indexed citations
9.
Murphy, Cormac D., Ali Mobasheri, Zsuzsanna Táncos, Julianna Kobolák, & András Dinnyés. (2017). The Potency of Induced Pluripotent Stem Cells in Cartilage Regeneration and Osteoarthritis Treatment. Advances in experimental medicine and biology. 1079. 55–68. 25 indexed citations
10.
Murphy, Cormac D.. (2016). Microbial degradation of fluorinated drugs: biochemical pathways, impacts on the environment and potential applications. Applied Microbiology and Biotechnology. 100(6). 2617–2627. 49 indexed citations
11.
Sweeney, Paul, Cormac D. Murphy, & Patrick Caffrey. (2015). Exploiting the genome sequence of Streptomyces nodosus for enhanced antibiotic production. Applied Microbiology and Biotechnology. 100(3). 1285–1295. 21 indexed citations
12.
Murphy, Cormac D., et al.. (2015). Towards an effective biosensor for monitoring AD leachate: a knockout E. coli mutant that cannot catabolise lactate. Applied Microbiology and Biotechnology. 99(23). 10209–10214. 9 indexed citations
13.
Clark, Benjamin R., et al.. (2013). Isolation and characterisation of actinomycin D producing Streptomyces spp. from Sudanese soil. AFRICAN JOURNAL OF BIOTECHNOLOGY. 12(19). 2624–2632. 10 indexed citations
14.
Casey, Eoin, et al.. (2013). Filamentous fungal biofilm for production of human drug metabolites. Applied Microbiology and Biotechnology. 97(13). 5955–5963. 28 indexed citations
15.
Murphy, Cormac D.. (2011). The microbial cell factory. Organic & Biomolecular Chemistry. 10(10). 1949–1949. 26 indexed citations
16.
Murphy, Cormac D., et al.. (2010). Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella species. Biotechnology Letters. 33(2). 321–326. 20 indexed citations
17.
Murphy, Cormac D., et al.. (2009). Metabolism of fluoroorganic compounds in microorganisms: impacts for the environment and the production of fine chemicals. Applied Microbiology and Biotechnology. 84(4). 617–629. 54 indexed citations
18.
Murphy, Cormac D.. (2006). Recent developments in enzymatic chlorination. Natural Product Reports. 23(2). 147–147. 29 indexed citations
19.
Cobb, Steven L., et al.. (2004). A F NMR study of fluorobenzoate biodegradation by sp. HB-1. FEMS Microbiology Letters. 237(2). 355–361. 1 indexed citations
20.
O’Hagan, David, Christoph Schaffrath, Steven L. Cobb, John T. G. Hamilton, & Cormac D. Murphy. (2002). Biosynthesis of an organofluorine molecule. Nature. 416(6878). 279–279. 345 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026